Brief Article
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 21, 2014; 20(7): 1839-1845
Published online Feb 21, 2014. doi: 10.3748/wjg.v20.i7.1839
Table 3 Univariate analysis for risk factors of delayed bleeding n (%)
VariableDelayed bleedingNon-bleedingP value
Number of patients 14303
Number of lesions 14311
Patient-related factors
Median age (yr) (range)68 (29-79)67 (31-86)0.871
Gender (male/female)7/6175/124> 0.999
Comorbidities
Hypertension5 (35.7)103 (33.1)> 0.999
Diabetes mellitus1 (7.1)34 (10.9)> 0.999
Hyperlipidemia2 (14.3)52 (16.7)> 0.999
Cardiovascular disease1 (7.1) 17 (5.5)0.557
Use of antithrombotic drugs1 (7.1) 27 (8.7)> 0.999
Use of intravenous heparin 0 (0)6 (1.9)> 0.999
Lesion related factors
Mean size of tumor (mm) (range)40.9 (20-70)33.8 (7-115)0.070
Mean size of specimen (mm) (range)45.4 (20-75)38.4 (8-120)0.142
Location0.042
Cecum4 (28.6) 19 (6.1)
Ascending colon3 (21.4)55 (17.7)
Transverse colon2 (14.3)49 (15.8)
Descending colon 0 (0) 12 (3.9)
Sigmoid colon1 (7.1)58 (18.6)
Rectum4 (28.6) 118 (37.9)
Morphology0.897
Protruded1 (7.1) 30 (9.6)
Depressed 0 (0) 4 (1.3)
LST-G9 (64.3) 171 (55.0)
LST-NG4 (28.6) 106 (34.1)
Histology and depth0.312
Serrated lesion 0 (0)5 (1.6)
Adenoma2 (14.3) 24 (7.7)
M8 (57.1) 241 (77.5)
SM < 1000 μm3 (21.4) 24 (7.7)
SM ≥ 1000 μm1 (7.1) 17 (5.5)
Treatment-related factors
Device used
Needle type1/scissor type212/2280/310.642
Mean procedure time (min) (range)90.4 (20-180)101.5 (10-630)0.965
Significant bleeding during ESD2 (14.3)4 (1.3)0.024